Literature DB >> 32561072

No pleotropic effects of linagliptin on atherosclerotic plaques: Case closed.

Mouaz H Al-Mallah1, Fabien Hyafil2, Gaetano Santulli3.   

Abstract

Entities:  

Keywords:  Atherosclerosis; Diabetes; Linagliptin

Mesh：

Substances：

Year:  2020        PMID： 32561072      PMCID： PMC7535087          DOI： 10.1016/j.atherosclerosis.2020.05.009

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  18 in total

1.  Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes.

Authors:  Jenni Virta; Sanna Hellberg; Heidi Liljenbäck; Mia Ståhle; Johanna M U Silvola; Jenni Huusko; Mirva Söderström; Juhani Knuuti; Pirjo Nuutila; Seppo Ylä-Herttuala; Maria F Gomez; Anne Roivainen; Antti Saraste
Journal:  Atherosclerosis       Date:  2020-04-10       Impact factor: 5.162

Review 2.  Assessment of myocardial perfusion and function with PET and PET/CT.

Authors:  Mouaz H Al-Mallah; Arkadiusz Sitek; Stephen C Moore; Marcelo Di Carli; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2010-06       Impact factor: 5.952

3.  Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.

Authors:  Tsutomu Hirano; Satoko Yamashita; Masaki Takahashi; Hiroyuki Hashimoto; Yusaku Mori; Moritaka Goto
Journal:  Metabolism       Date:  2016-03-18       Impact factor: 8.694

4.  DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages.

Authors:  C Brenner; W M Franz; S Kühlenthal; K Kuschnerus; F Remm; L Gross; H D Theiss; U Landmesser; N Kränkel
Journal:  Int J Cardiol       Date:  2015-07-13       Impact factor: 4.164

5.  Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

Authors:  Nobuhiro Tahara; Hisashi Kai; Masatoshi Ishibashi; Hiroyuki Nakaura; Hayato Kaida; Kenkichi Baba; Naofumi Hayabuchi; Tsutomu Imaizumi
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

Review 6.  Nuclear Imaging: Focus on Vascular Probes

Authors:  Fabien Hyafil; Jonathan Vigne
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-23       Impact factor: 8.311

7.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.

Authors:  Ahmed Tawakol; Raymond Q Migrino; Gregory G Bashian; Shahinaz Bedri; David Vermylen; Ricardo C Cury; Denise Yates; Glenn M LaMuraglia; Karen Furie; Stuart Houser; Henry Gewirtz; James E Muller; Thomas J Brady; Alan J Fischman
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

8.  Cardiorespiratory fitness and incident diabetes: the FIT (Henry Ford ExercIse Testing) project.

Authors:  Stephen P Juraschek; Michael J Blaha; Roger S Blumenthal; Clinton Brawner; Waqas Qureshi; Steven J Keteyian; John Schairer; Jonathan K Ehrman; Mouaz H Al-Mallah
Journal:  Diabetes Care       Date:  2015-03-12       Impact factor: 19.112

9.  Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright
Journal:  N Engl J Med       Date:  2012-11-05       Impact factor: 91.245

10.  Editorial: Cardiovascular Disease and Diabetes.

Authors:  Gaetano Santulli
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-16       Impact factor: 5.555
View more
  1 in total

1.  miR-7 Regulates GLP-1-Mediated Insulin Release by Targeting β-Arrestin 1.

Authors:  Alessandro Matarese; Jessica Gambardella; Angela Lombardi; Xujun Wang; Gaetano Santulli
Journal:  Cells       Date:  2020-07-06       Impact factor: 6.600
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.